Works matching IS 08926638 AND DT 2002 AND VI 16 AND IP 12


Results: 39
    1
    2

    Erratum.

    Published in:
    2002
    Publication type:
    Correction Notice
    3
    4

    Characterization of a novel metabolic strategy used by drug‐resistant tumor cells.

    Published in:
    FASEB Journal, 2002, v. 16, n. 12, p. 1550, doi. 10.1096/fj.02-0541com
    By:
    • Harper, Mary‐Ellen;
    • Antoniou, Andreas;
    • Villalobos‐Menuey, Elizabeth;
    • Russo, Alicia;
    • Trauger, Richard;
    • Vendemelio, Minda;
    • George, Amanda;
    • Bartholomew, Richard;
    • Carlo, Dennis;
    • Shaikh, Azhar;
    • Kupperman, Jami;
    • Newell, Evan W.;
    • Bespalov, Ivan A.;
    • Wallace, Susan S.;
    • Liu, Ye;
    • Rogers, Jeffrey R.;
    • Gibbs, Gregory L.;
    • Leahy, Jack L.;
    • Camley, Robert E.;
    • Melamede, Robert
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Protection of innate immunity by C5aR antagonist in septic mice.

    Published in:
    FASEB Journal, 2002, v. 16, n. 12, p. 1567, doi. 10.1096/fj.02-0209com
    By:
    • Huber‐Lang, Markus S.;
    • Riedeman, Niels C.;
    • Sarma, J. Vidya;
    • Younkin, Ellen M.;
    • McGuire, Stephanie R.;
    • Laudes, Ines J.;
    • Lu, Kristina T.;
    • Guo, Ren‐Feng;
    • Neff, Thomas A.;
    • Padgaonkar, Vaishalee A.;
    • Lambris, John D.;
    • Spruce, L.;
    • Mastellos, D.;
    • Zetoune, Firas S.;
    • Ward, Peter A.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39